Atossa Therapeutics (NASDAQ: ATOS) is an early-stage biopharmaceutical that is slowly making progress with a Covid-19-related treatment. ATOS stock has been declining, given that investors
When markets undergo heavy macroeconomic stresses and unpredictable volatility, investors typically turn to stocks that are capable of delivering stability. This article aims to shed
For investors looking at the stock market, perhaps the most important objective is the prospect of growth. While many retail traders prefer to beat the
The Lithium industry is one that many claims is on the verge of a price explosion. With increasing momentum in the shift towards electric vehicles,
Introduction Penny stocks, particularly those that trade below the $1 mark is notorious for being risky bets. This is because of their nature of being
Introduction Inflation, interest rate hikes, and a potential looming recession. These are terms that no investor is ever keen to hear. Yet these are some
Solar stocks are growing in dominance with the rising global demand for renewable sources of energy. The overall energy demand has skyrocketed since the opening
Markets today are full of warning signs for investors as the world sinks deep into chaos ensued by numerous factors. Covid-19 pandemic played its part
In the beverages/soft drinks industry with numerous headwinds and certain tailwinds, one of the leaders, Keurig Dr. Pepper Inc. (KDP) has received a consensus buy
Late on June 2, 2022, the work management platform developer, Asana Inc. (ASAN) posted earnings for the first quarter of fiscal 2023. The earnings were
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.